ROCKET PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rocket Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • Rocket Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $11.3M, a 10.6% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $41.8M, a 14.5% increase year-over-year.
  • Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $39.4M, a 27.1% increase from 2022.
  • Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31M, a 6.06% increase from 2021.
  • Rocket Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $29.2M, a 57.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $39.4M +$8.4M +27.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $31M +$1.77M +6.06% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $29.2M +$10.7M +57.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $18.6M +$5.2M +38.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $13.4M -$230K -1.69% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $13.6M +$12.3M +930% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $1.32M +$1.05M +382% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-08
2016 $274K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2014 $7.00* Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.